Home › Kanser (lahat ng uri) › Florida
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Florida
127 pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
- Tampa38 pag-aaral
- Miami36 pag-aaral
- Jacksonville29 pag-aaral
- Orlando24 pag-aaral
- Sarasota10 pag-aaral
- Gainesville9 pag-aaral
- Plantation7 pag-aaral
- Cape Coral7 pag-aaral
- Fort Lauderdale6 pag-aaral
- Hollywood6 pag-aaral
- St. Petersburg6 pag-aaral
- Deltona5 pag-aaral
- Coral Springs5 pag-aaral
- Davie5 pag-aaral
- Kendall4 pag-aaral
- Hialeah4 pag-aaral
- Boca Raton3 pag-aaral
- Deerfield Beach3 pag-aaral
- Miami Beach3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Boca Raton Clinical Research Coral Springs, Coral Springs
- Regis Clinical Research LLC, Miami
- Florida Clinical Trials Group Tamarac, Tamarac
Nagre-recruitPhase 3
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, Pembroke Pines
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07672769A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003), Miami
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06818643000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- Mayo Clinic Flordia, Jacksonville
Nagre-recruitPhase 1/2
Edad 15 hanggang 99 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05588141A Study of YL242 in Subjects With Advanced Solid Tumors
- US-202, Sarasota
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07197827Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- University of Miami, Miami
- Moffitt Cancer Center, Tampa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06423950KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Clermont Oncology Center ( Site 0041), Clermont
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07252739RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Holy Cross Hospital, Fort Lauderdale
- Broward Health Medical Center, Fort Lauderdale
- UF Health Cancer Institute - Gainesville, Gainesville
- at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07195591A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Florida Cancer Specalists, Sarasota
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06983743Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05655494REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- Bioresearch Partner- Hialeah Hospital, Hialeah
- Helios Clinical Research, North Miami Beach
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07410117A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- Florida Clinical Trials Group, Plantation
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07540572A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- BRCR Global - Tamarac, Tamarac
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Moffit Cancer center, Tampa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Millennium Oncology Research Clinic, Hollywood
- Miami Cancer Institute at Baptist Health, Inc., Miami
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
- at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06119581A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07578571A Study of JNJ-1761981 in Participants With Solid Tumors
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07525141Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- The Mayo Clinic - Jacksonville, Davis-E, Jacksonville
- Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami
- Baptist Cancer Center, Miami
- at 2 pa
Nagre-recruitPhase 2/3
Lahat ng edad · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03435796A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06010329Visugromab in Cachexia International Trial
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Centers, Orange City
- Cleveland Clinic Martin Health, Stuart
- at 1 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07112196A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 4025), St. Petersburg
Nagre-recruitPhase 1/2
1 Month – 17 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07630974Met Non Small Cell Cancer Registry (MOMENT)
- Holy Cross Health, Fort Lauderdale
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT05376891Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment
- Mayo Clinic in Florida, Jacksonville
Nagre-recruit
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07221409Multi-Cancer Detection Observational Cohort Study
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 21 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06962995A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Orlando
- Research Site, Tampa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06835569Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT04981119Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Miami VA Healthcare System, Miami, FL, Miami
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT02984761A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Sylvester Comprehensive Cancer Center, Miami
- Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Okt 20, 2026 · NCT07103018A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- Moffitt Cancer Center /ID# 279068, Tampa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07409246A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Moffitt Cancer Center /ID# 272628, Tampa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06892522Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Boca Raton Clinical Research Associates, Plantation
- H Lee Moffitt Cancer Center and Research Institute, Tampa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT06162221Galleri® in the Medicare Population.
- USF Morsani Center for Advanced Healthcare, Tampa
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05673018INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06008392A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06989437A Study of ASP3082 in Adults With Advanced Solid Tumors
- University of Florida, Davis Cancer Center, Gainesville
- Florida Cancer Specialists & Research Institute Sarasota, Sarasota
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT05382559A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- University of Miami, Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07725796A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Mayo Clinic Hospital Jacksonville /ID# 274472, Jacksonville
- Moffitt Cancer Center /ID# 274372, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07023289Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.